Authors: Loprevite, M Favoni, RE de Cupis, A Pirani, P Pietra, G Bruno, S Grossi, F Scolaro, T Ardizzoni, A

Citation: M. Loprevite et al., Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines, LUNG CANC, 33(1), 2001, pp. 27-39

Authors: Favoni, RE De Cupis, A

Citation: Re. Favoni et A. De Cupis, The role of polypeptide growth factors in human carcinomas: New targets for a novel pharmacological approach, PHARM REV, 52(2), 2000, pp. 179-206

Authors: De Cupis, A Schettini, G Favoni, RE

Citation: A. De Cupis et al., New vs old fashioned oestradiol antagonists in mammary carcinoma: 'In vitro' and 'in vivo' pharmacological approaches, PHARMAC RES, 39(5), 1999, pp. 335-344

Authors: Loprevite, M Favoni, RE de Cupis, A Pirani, P Merlo, F Grossi, F Ardizzoni, A

Citation: M. Loprevite et al., Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity, INT J ONCOL, 15(4), 1999, pp. 787-792

Authors: Orengo, AM Procopio, A Favoni, RE De Cupis, A Ardizzoni, A Castagneto, B Ribotta, M Detta, PG Ferrini, S Mutti, L

Citation: Am. Orengo et al., Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis, EUR RESP J, 13(3), 1999, pp. 527-534

Authors: de Cupis, A Pirani, P Fazzuoli, L Favoni, RE

Citation: A. De Cupis et al., Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: Comparison between early and late cultures, IN VITRO-AN, 34(10), 1998, pp. 836-843